Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "Multiple enzymes and cellular components" is a non-specific designation used in pharmacological databases to classify agents that do not interact with a single, well-defined molecular target (DrugBank, 2024). Instead, these agents exert their therapeutic or toxic effects by interacting with a broad array of proteins, enzymes, nucleic acids, or lipid membranes within the cell (NCBI, 2023). This classification is frequently applied to cytotoxic chemotherapy agents like alkylating agents, which damage DNA and inhibit numerous enzymes involved in replication, or to antiseptic agents that disrupt cellular integrity globally (StatPearls, 2023). For example, ethanol and other alcohols act by fluidizing cell membranes and denaturing a wide variety of intracellular proteins rather than binding to a specific receptor (PubMed, 2022). Because of this lack of specificity, such agents often have a wide range of biological effects and a higher potential for systemic toxicity compared to targeted therapies. In a clinical context, this label serves as a placeholder when the primary effect is the result of a cumulative impact on the cellular environment rather than a discrete signaling pathway (NIH, 2024). Consequently, it is considered an imprecise target definition for modern drug discovery, which typically favors high-affinity interactions with specific molecular entities.
Non-specific chemical modification of proteins and nucleic acids, or physical disruption of cellular membranes and organelles.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple enzymes and cellular components.